AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 20705980
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of tubewells, Clorin, and hygiene promotion
Trial: 2766870
Drug: Perioperative antibiotic
RxNorm normalized name: ENSURE SURGERY PERIOPERATIVE KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative antibiotic prophylaxis with 2 x 2 g ceftriaxone (Rocephin)
Trial: 26041028
Drug: Intravenous ferric
RxNorm normalized name: Ferric Oxide
DrugBank: Ferric oxide (DB11576)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ferric carboxymaltose (1000 mg)
Trial: 23853552
Drug: Twice weekly
RxNorm normalized name: Alora 0.1 MG/Day Twice Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice weekly iron‐folic acid (IFA)
Trial: 23853552
Drug: Twice weekly
RxNorm normalized name: Alora 0.1 MG/Day Twice Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice weekly multiple micronutrient (MMN)
Trial: 23853552
Drug: Daily iron‐folic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily iron‐folic acid (IFA)
Trial: 21160152
Drug: Lidocaine gel
RxNorm normalized name: LIDOCAINE 4 g in 100 g EXTRACORPOREAL PATCH [Arthcal 4% Lidocaine Gel Patches]
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine gel (Instillagel®) during GIS
Trial: 21160152
Drug: Gel without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gel without lidocaine (Endosgel®) during GIS
Trial: 21160152
Drug: Lidocaine gel
RxNorm normalized name: LIDOCAINE 4 g in 100 g EXTRACORPOREAL PATCH [Arthcal 4% Lidocaine Gel Patches]
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine gel (Instillagel®) during hysteroscopy
Trial: 21160152
Drug: Gel without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gel without lidocaine (Endosgel®) during hysteroscopy
Trial: 19557003
Drug: Increased dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased dose of angiotensin‐II receptor blocker (ARB)
Trial: 19557003
Drug: Maintenance dose
RxNorm normalized name: Firmagon 80mg Powder for Injection Maintenance Dose Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance dose of ARB plus calcium channel blocker (amlodipine)
Trial: 16485881
Drug: 0.5% fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% fluorouracil cream (FC) applied once daily for 7 days
Trial: 16485881
Drug: Vehicle cream
RxNorm normalized name: vehicle cream base no.160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle cream (VC) applied once daily for 7 days
Trial: 8284632
Drug: Sucralfate (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate (1 g four times daily for 3 weeks)
Trial: 3126024
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy recruitment
Trial: 25212062
Drug: Obesity prevention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Obesity prevention intervention programme delivered by teachers promoting physical activity and healthy eating; specific dosage and duration not mentioned.
Trial: 17643572
Drug: Atorvastatin alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin alone (single therapy), placebos for ER-niacin and colesevelam
Trial: 17643572
Drug: Atorvastatin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin plus ER-niacin (2 g/d), placebo for colesevelam (double therapy)
Trial: 17643572
Drug: Atorvastatin, ER-niacin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin, ER-niacin, plus colesevelam (3.8 g/d) (triple therapy)
Trial: 17643572
Drug: Placebo for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo for ER-niacin and colesevelam (single therapy)
Trial: 9260213
Drug: Ice water
RxNorm normalized name: CVS Electrolyte Solution with Zinc (Rice Water)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ice water ingestion (250 ml of 0‐4 degrees C)
Trial: 9260213
Drug: Warm water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warm water ingestion (250 ml of 25 degrees C)
Trial: 30354231
Drug: Heme arginate
RxNorm normalized name: Heme arginate
DrugBank: Heme arginate (DB17310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heme arginate 1 mg/kg
Trial: 30354231
Drug: Heme arginate
RxNorm normalized name: Heme arginate
DrugBank: Heme arginate (DB17310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heme arginate 3 mg/kg
Trial: 30354231
Drug: Heme arginate
RxNorm normalized name: Heme arginate
DrugBank: Heme arginate (DB17310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heme arginate infusion
Trial: 24606105
Drug: Usual anti-hyperglycemic
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual anti-hyperglycemic therapy
Trial: 22915615
Drug: Tumour necrosis
RxNorm normalized name: Tumour necrosis factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tumour necrosis factor inhibitor
Trial: 16948965
Drug: Topical salicylate
RxNorm normalized name: salicylic acid Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical salicylate
Trial: 16948965
Drug: Er:Yag laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Er:Yag laser therapies
Trial: 8795326
Drug: Midazolam (0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.04 mg.kg‐1) and Alfentanil (10 micrograms.kg‐1) followed by Propofol (1.25 mg.kg‐1)
Trial: 8795326
Drug: Alfentanil (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil (10 micrograms.kg‐1) followed by Propofol (1.25 mg.kg‐1)
Trial: 8795326
Drug: Propofol only
RxNorm normalized name: Propofol only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol only (2.5 mg.kg‐1)
Trial: 1621413
Drug: Intranasal aerosol
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal aerosol administration of quadrivalent inactivated split influenza vaccine
Trial: 1621413
Drug: Subcutaneous administration
RxNorm normalized name: subcutaneous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous administration of quadrivalent inactivated split influenza vaccine
Trial: 1621413
Drug: Saline intranasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline intranasal administration
Trial: 26866433
Drug: Dexamethasone 4
RxNorm normalized name: dexamethasone 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 4 mg after tracheal intubation and ondansetron 4 mg during skin closure
Trial: 24419137
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of MSC and LDCT
Trial: 22429268
Drug: 5-fluorouracil plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-fluorouracil plus bevacizumab (1.25 mg/0.05 mL)
Trial: 22429268
Drug: 5-fluorouracil only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-fluorouracil only (7.5 mg/0.15 mL)
Trial: 17233688
Drug: Psychiatric intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Psychiatric intervention (treatment study)
Trial: 10971683
Drug: Colloidal bismuth
RxNorm normalized name: Colloidal bismuth subcitrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colloidal bismuth subcitrate (one tablet qds) + amoxicillin (500 mg qds) + metronidazole (400 mg tds)
Trial: 10971683
Drug: Bismuth subnitrate
RxNorm normalized name: Bismuth subnitrate
DrugBank: Bismuth subnitrate (DB13209)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bismuth subnitrate (two tablets tds) + amoxicillin (500 mg qds) + metronidazole (400 mg tds)
Trial: 10971683
Drug: Placebo bismuth
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo bismuth (two tablets tds) + amoxicillin (500 mg qds) + metronidazole (400 mg tds)
Trial: 10971683
Drug: Bismuth subnitrate
RxNorm normalized name: Bismuth subnitrate
DrugBank: Bismuth subnitrate (DB13209)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bismuth subnitrate (two tablets tds) + placebo antibiotics
Trial: 8967617
Drug: Pentaglobin therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentaglobin therapy (Group 1)
Trial: 8967617
Drug: No immunoglobulin
RxNorm normalized name: immunoglobulin A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No immunoglobulin therapy (Group 2)
Trial: 1474536
Drug: Indomethacin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (75 mg/day)
Trial: 6439566
Drug: SUL (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SUL (1 mg/kg i.m.)
Trial: 6439566
Drug: SUL +
RxNorm normalized name: dihydralazine sul hemipenthy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SUL + PL (2 ml saline i.v.)
Trial: 6439566
Drug: SUL +
RxNorm normalized name: dihydralazine sul hemipenthy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SUL + TRH (200 mcg i.v.)
Trial: 6439566
Drug: TRH (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRH (200 mcg i.v.)
Trial: 16825847
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy (once a day for 3 days, 30-60 minutes per day)
Trial: 8675168
Drug: UDCA (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UDCA (15 mg/kg body weight daily) plus taurine (30 mg/kg body weight daily)
Trial: 30355117
Drug: IVT+MT (in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVT+MT (in patients without anticoagulant medication before stroke onset)
Trial: 24884885
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg of folic acid (FA) daily
Trial: 24884885
Drug: 0.4 mg
RxNorm normalized name: biotin 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg of folic acid (FA) daily
Trial: 23157895
Drug: Behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral treatment with naltrexone (22-week comprehensive intervention)
Trial: 19378423
Drug: Antioxidant supplementation
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant supplementation (400 mg vitamin C and 180 mg vitamin E d(‐1) and 200 mg BiO‐Quinon Q10 d(‐1))
Trial: 15339559
Drug: Jianpi Huoxue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jianpi Huoxue Jiedu (JPHXJD) prescription combined with chemotherapy
Trial: 10229744
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Verapamil and Trandolapril
Trial: 8722437
Drug: Calcium antagonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium antagonist (amlodipine)
Trial: 8722437
Drug: Angiotensin converting
RxNorm normalized name: Angiotensin converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin converting enzyme inhibitor (lisinopril)
Trial: 8722437
Drug: HMG CoA
RxNorm normalized name: HMG CoA reductase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HMG CoA reductase inhibitor (pravastatin)
Trial: 27955918
Drug: Dexmedetomidine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (50 µg) added to lidocaine (9.5 mL) and ropivacaine (10 mL)
Trial: 27955918
Drug: Saline (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (0.5 mL) added to lidocaine (9.5 mL) and ropivacaine (10 mL)
Trial: 17453654
Drug: Protocolized pharmacotherapy
RxNorm normalized name: Olay Professional Acne Protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocolized pharmacotherapy with nortriptyline
Trial: 17453654
Drug: Protocolized pharmacotherapy
RxNorm normalized name: Olay Professional Acne Protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocolized pharmacotherapy with nortriptyline-plus-lithium
Trial: 15189389
Drug: Aspirin, beta-blockers,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin, beta-blockers, and angiotensin converting enzyme inhibitors
Trial: 11699982
Drug: Antimicrobial agents
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial agents for caries management
Trial: 9688168
Drug: DHA-rich fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA-rich fish oil capsules containing 1.5 g DHA
Trial: 9688168
Drug: Control oil
RxNorm normalized name: SALICYLIC ACID 29.2 mg TOPICAL LIQUID [Acne Control oil-free Cleansing]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control oil capsules containing 97% soybean oil plus 3% of another fish oil
Trial: 28992884
Drug: Intravenous moxifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous moxifloxacin (400 mg/day)
Trial: 28992884
Drug: Ceftriaxone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone (2 g/day)
Trial: 26357467
Drug: LC350189 (10-600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LC350189 (10-600 mg single ascending dose)
Trial: 26357467
Drug: LC350189 (100-800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LC350189 (100-800 mg multiple ascending dose for 7 days)
Trial: 26357467
Drug: LC350189 (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LC350189 (200 mg)
Trial: 23851699
Drug: Vitamin D-fortified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D-fortified growing up milk (2.85 μg/100 ml)
Trial: 19224790
Drug: Target-controlled infusion
RxNorm normalized name: Diphtheria toxin-il-3 fusion protein targeting IL-3 receptor
DrugBank: Tagraxofusp (DB14731)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Target-controlled infusion (TCI) remifentanil (1 ng/mL)
Trial: 19224790
Drug: Manually controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manually controlled continuous infusion (MCI) remifentanil (0.125 microg x kg(‐1) x min(‐1) for 2 min followed by 0.05 microg x kg(‐1) x min(‐1))
Trial: 19224790
Drug: Placebo (normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (normal saline either as TCI or manual infusion of equivalent rate)
Trial: 11079647
Drug: Abciximab with
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Abciximab with reduced-dose reteplase (5 U double bolus)
Trial: 9387746
Drug: Antithyroid drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antithyroid drugs (Tapazol and inderal, etc.)
Trial: 9387746
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal medicine for tonifying Kidney and promoting blood circulation
Trial: 1549034
Drug: Diphenhydramine hydrochloride
RxNorm normalized name: Diphenhydramine Hydrochloride
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diphenhydramine hydrochloride (50 mg)
Trial: 381093
Drug: Cimetidine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (300 mg four times daily)
Trial: 26866405
Drug: 2-stage injection
RxNorm normalized name: SAGE
DrugBank: Sage (DB10982)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-stage injection technique
Trial: 20383871
Drug: EPO treatment
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EPO treatment at a fixed dose of 50 IU/kg per week to increase hemoglobin level to a maximum of 13.7 g/dL for men and 13.4 g/dL for women.
Trial: 20383871
Drug: EPO treatment
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EPO treatment at a fixed dose of 50 IU/kg per week maintaining baseline hemoglobin levels for the first 6 months by phlebotomy.
Trial: 16293867
Drug: Standard chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard chemotherapy (cyclophosphamide, doxorubicin, etoposide; cisplatin and etoposide)
Trial: 16293867
Drug: ICE-V regimen
RxNorm normalized name: Anacin Aspirin Regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICE-V regimen and Standard chemotherapy
Trial: 12564654
Drug: Formoterol fumarate
RxNorm normalized name: Formoterol Fumarate
DrugBank: Formoterol (DB00983)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Formoterol fumarate (Foradil) 12 microg taken twice daily
Trial: 12564654
Drug: Formoterol fumarate
RxNorm normalized name: Formoterol Fumarate
DrugBank: Formoterol (DB00983)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Formoterol fumarate (Foradil) 24 microg taken twice daily
Trial: 12564654
Drug: Formoterol fumarate
RxNorm normalized name: Formoterol Fumarate
DrugBank: Formoterol (DB00983)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Formoterol fumarate (Foradil) used as regular maintenance treatment and rescue medication
Trial: 12564654
Drug: Formoterol fumarate
RxNorm normalized name: Formoterol Fumarate
DrugBank: Formoterol (DB00983)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Formoterol fumarate (Foradil) total daily dose of 48 microg or less
Trial: 10214889
Drug: Azelastine hydrochloride
RxNorm normalized name: Azelastine Hydrochloride
DrugBank: Azelastine (DB00972)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Azelastine hydrochloride (AZ) 2 mg + S-carboxymethyl cysteine (SCMC) 750 mg
Trial: 10214889
Drug: S-carboxymethyl cysteine
RxNorm normalized name: (R)-S-(carboxymethyl)cysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-carboxymethyl cysteine (SCMC) 750 mg
Trial: 7611378
Drug: 1 mg/day
RxNorm normalized name: Lyllana 0.1 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/day digoxin
Trial: 30702997
Drug: Dual pathway
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual pathway inhibition with low-dose rivaroxaban (2.5 mg twice-daily) plus acetylsalicylic acid
Trial: 26717035
Drug: Conventional tacrolimus-based
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional tacrolimus-based therapy (TAC Control)
Trial: 21870979
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acids (1 g twice a day)
Trial: 10065662
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg patch for 22 weeks (L-25)
Trial: 10065662
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg patch for 8 weeks (S-25)
Trial: 10065662
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg patch for 22 weeks (L-15)
Trial: 10065662
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg patch for 8 weeks (S-15)
Trial: 7488408
Drug: Postoperative platinum-based
RxNorm normalized name: platinum
DrugBank: Platinum (DB12257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative platinum-based chemotherapy (two cycles)
Trial: 1962154
Drug: Pulsed ultrasound
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed ultrasound treatment (1 MHz; 1:4; 1 W/cm2, 10 min/session, 2-3 times weekly for 10 treatments)
Trial: 26071040
Drug: TXA 1
RxNorm normalized name: Tranexamic acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TXA 1 g
Trial: 23873583
Drug: Double therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double therapy (peginterferon α‐2b and ribavirin for 20 weeks)
Trial: 23873583
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (peginterferon α‐2b, ribavirin, and boceprevir for 24 weeks)
Trial: 22313979
Drug: Adper Prompt‐L‐Pop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adper Prompt‐L‐Pop
Trial: 20571786
Drug: teriparatide treatment
RxNorm normalized name: Teriparatide
DrugBank: Teriparatide (DB06285)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: teriparatide treatment (20 microg/day)
Trial: 2261895
Drug: Full cream
RxNorm normalized name: Full Marks
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full cream cows' milk or low lactose formula
Trial: 6805002
Drug: Pimozide (10-70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pimozide (10-70 mg/day, median 30 mg/day)
Trial: 6805002
Drug: Chlorpromazine (600-1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (600-1500 mg/day, median 900 mg/day)
Trial: 28727908
Drug: MK-8666 500
RxNorm normalized name: vitamin MK 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-8666 500 mg
Trial: 28727908
Drug: MK-8666 150
RxNorm normalized name: MK-8666
DrugBank: MK-8666 (DB14937)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-8666 150 mg
Trial: 28727908
Drug: MK-8666 50
RxNorm normalized name: vitamin MK 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-8666 50 mg
Trial: 26348088
Drug: Sertraline (SRT)
DrugBank: Sertraline (DB01104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sertraline (SRT) treatment, maximum dose 200 mg/day, over 72-300 days (mean=164.2, SD=68.3).
Trial: 23566419
Drug: Celecoxib (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (400 mg) twice daily for two to three weeks (n = 22)
Trial: 19549430
Drug: Mometasone 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mometasone 400 micrograms once daily for 12 weeks
Trial: 15143476
Drug: 11PncTD1 (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 11PncTD1 (1 dose of adjuvanted, 11-valent pneumococcal conjugate vaccine)
Trial: 15143476
Drug: 11PncTD3 (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 11PncTD3 (3 doses of adjuvanted, 11-valent pneumococcal conjugate vaccine)
Trial: 8729585
Drug: Fluvastatin 20
RxNorm normalized name: fluvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 20 mg and 40 mg